- Home
- BRZE vs APLS Comparison
BRZE vs APLS Comparison
Compare BRZE & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRZE
- APLS
- Stock Information
- Founded
- BRZE 2011
- APLS 2009
- Country
- BRZE United States
- APLS United States
- Employees
- BRZE N/A
- APLS N/A
- Industry
- BRZE Computer Software: Prepackaged Software
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- BRZE Technology
- APLS Health Care
- Exchange
- BRZE Nasdaq
- APLS Nasdaq
- Market Cap
- BRZE 3.0B
- APLS 3.3B
- IPO Year
- BRZE 2021
- APLS 2017
- Fundamental
- Price
- BRZE $29.21
- APLS $18.20
- Analyst Decision
- BRZE Strong Buy
- APLS Buy
- Analyst Count
- BRZE 21
- APLS 18
- Target Price
- BRZE $53.10
- APLS $45.59
- AVG Volume (30 Days)
- BRZE 1.7M
- APLS 2.8M
- Earning Date
- BRZE 06-05-2025
- APLS 05-06-2025
- Dividend Yield
- BRZE N/A
- APLS N/A
- EPS Growth
- BRZE N/A
- APLS N/A
- EPS
- BRZE N/A
- APLS N/A
- Revenue
- BRZE $593,410,000.00
- APLS $781,367,000.00
- Revenue This Year
- BRZE $17.90
- APLS $12.71
- Revenue Next Year
- BRZE $16.88
- APLS $20.93
- P/E Ratio
- BRZE N/A
- APLS N/A
- Revenue Growth
- BRZE 25.78
- APLS 97.02
- 52 Week Low
- BRZE $27.75
- APLS $17.49
- 52 Week High
- BRZE $48.33
- APLS $53.06
- Technical
- Relative Strength Index (RSI)
- BRZE 37.59
- APLS 28.14
- Support Level
- BRZE $27.98
- APLS $18.00
- Resistance Level
- BRZE $33.17
- APLS $19.71
- Average True Range (ATR)
- BRZE 2.05
- APLS 1.63
- MACD
- BRZE -0.36
- APLS -0.16
- Stochastic Oscillator
- BRZE 15.50
- APLS 10.98
About BRZE Braze Inc.
Braze Inc is a customer engagement platform that powers customer-centric interactions between consumers and brands. The company provides solutions for Retail & E-commerce, Media & Entertainment, Financial Services, and Travel & Hospitality related industries. The company offers a single, vertically integrated platform that encompasses the various functionalities, or layers, required for modern customer engagement: data ingestion, classification, orchestration, personalization, and action, all of which is supported by Sage AI by Braze, its AI engine designed to power AI functionality across all layers of this stack. It generates majority of its revenue from the United States.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.